Lilly Price Prediction: Case for Double-Digit Upside
Eli Lilly faces a pivotal year as its GLP-1 franchise powers revenue growth and new oral therapies expand addressable...
This article outlines scenarios where target date funds may be preferable to index funds in a 401(k), focusing on simplicity and risk management.
26,105 articlesEli Lilly faces a pivotal year as its GLP-1 franchise powers revenue growth and new oral therapies expand addressable...
Ondas stock moved sharply higher after a strong Q1 revenue beat and higher full-year guidance. This piece breaks down...
Analysts see a constructive Alphabet stock price prediction as cloud momentum and AI investments gain traction. The f...
Nvidia's latest earnings moment features a clear signal from Jensen Huang about AI demand and strategic momentum. Thi...
Memory markets are shifting as mega-capex from Hynix and Samsung could ease shortages. Here's what that means for Mic...
A billionaire shifted away from cloud giants to AI infrastructure plays. This article explains what drove the move an...
Tesla faces a pivotal three-year outlook as margins recover and AI initiatives expand. Analysts sketch a base case ar...
When bond yields spiking higher, stock prices can face pressure, especially for growth-focused names. This guide brea...
The space-tech IPO has hit a snag, with shares slipping below the initial price. This guide breaks down what the drop...
Ares Capital has long dazzled income investors with a high dividend yield. After a challenging quarter, the question ...
Tech founder moves set a high bar for OpenAI's IPO. This article breaks down the reality behind altman called openai ...
Guggenheim started coverage on StubHub with a Buy rating and a $12.50 price target, signaling optimism for the live-e...